Neoadjuvant chemotherapy for locally advanced stage (IB2-IIA2-IIB) cervical carcinoma: Experience of a tertiary center and comprehensive review of the literature

• Published in: Turkish journal of obstetrics and gynecology 2021-09, Vol.18 (3), p.190-202
• Main Authors: Çakır, Caner, Kılıç, Fatih, Dur, Rıza, Yüksel, Dilek, Ünsal, Mehmet, Korkmaz, Vakkas, Kılıç, Çiğdem, Cömert, Günsu Kimyon, Boran, Nurettin, Türkmen, Osman, Koç, Sevgi, Turan, Taner
• Format: Article
• Language: English
• Subjects: Cancer; Cervical cancer; Chemotherapy; Clinical Investigation; Disease; General anesthesia; Hysterectomy; Kadın Hastalıkları; Lymphatic system; Magnetic resonance imaging; Metastasis; Oncology; Patients; Statistical analysis; Surgery; Tıp; Tomography
• ISSN: 2149-9322; 2149-9330
• DOI: 10.4274/tjod.galenos.2021.70493

Objective: This study aimed to evaluate neoadjuvant chemotherapy (NACT) for locally advanced stage cervical carcinoma. Materials and Methods: Data of 43 patients with locally advanced cervical carcinoma who had NACT were reviewed. NACT protocols implemented included cisplatin/5-fluorauracil, cisplatin/UFT, and carboplatin/paclitaxel. After NACT, the patients were re-examined, and patients who had a tumor size ≤40 mm underwent Piver-Rutledge type III radical hysterectomy, while other patients received radiotherapy. Following NACT, clinical responses were assessed according to the criteria of the World Health Organization. Results: The mean age of the patients was 49.4 years, and the median follow-up duration was 48 (range, 5-228) months. The median tumor sizes were 50 and 30 mm before and after NACT, respectively. Complete clinical response was observed in 4 (9.3%) patients, partial clinical response in 8 (18.6%), and pathologic complete response in 3 (6.9%). Stable disease was noted in 30 (69.9%) patients and progression in 1 (2.3%) patient. After NACT, 31 patients have undergone radical surgical procedures. The 5-year disease-free survival rate was 72%, and the 5-year disease-specific survival rate was 91%. Age, International Federation of Gynaecology and Obstetrics 2009 stage, histopathologic type, NACT protocol, rate of decrease in tumor size after NACT, clinical response, number of courses, tumor size before NACT, tumor size after NACT, and lymph node metastasis were not associated with disease-free survival. Conclusion: Following NACT, a significant reduction in tumor dimension was observed, and the probability of radical surgery is increased. However, clinical response was not predictive of survival.